Manufactures and sells specialty chemicals across three reported segments. Performance and Other Chemicals accounts for 71.0% of segment revenue (Rs 4,608.73 cr) while Life Science Chemicals contributes 27.8% (Rs 1,805.24 cr), and Others the remaining 1.2%. Operations span 4 manufacturing plants and 8 offices in India, with products sold in over 40 countries and exports making up 42% of sales. The company carries a crop protection retail portfolio of 59 brands across major Indian crops, and runs a pharmaceuticals business under a senior vice president. Raw materials are the largest cost at 51.9% of revenue. Atul is debt-free with a net cash surplus, has approved a Rs 167 crore greenfield capex for MCPP-p (1,000 tpa) and MCPA (750 tpa) herbicides capacity due to complete in 67 weeks, and formed a 50:50 JV with Buckman USA in February 2026. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Performance and Other Chemicals (71%), Life Science Chemicals (28%), Others (1%). Diversified specialty chemicals manufacturer; materials-heavy cost base, debt-free.
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 5,081 | 5,428 | 4,726 | 5,583 | 6,274 |
| EBITDA (ex other income) | 911 | 779 | 637 | 913 | 1,037 |
| margin % | 17.9 | 14.3 | 13.5 | 16.4 | 16.5 |
| Owners' profit | 597 | (89) | 323 | 484 | 678 |
| EPS, as reported (₹) | 204.23 | 174.15 | 109.54 | 164.37 | 230.25 |
| ROE % · ROCE % | 13.4 · 17.2 | 10.7 · 14.1 | 6.3 · 8.1 | 8.8 · 11.5 | 10.9 · 13.5 |
| Debt / equity (x) | 0.03 | 0.01 | 0.04 | 0.03 | 0.03 |
| Cash from operations | 231 | 707 | 667 | 603 | 1,023 |
| Capex | (591) | (875) | (504) | (270) | (175) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,393 | 1,417 | 1,452 | 1,478 | 1,552 | 1,574 | 1,670 | 1,848 |
| Profit before tax | 188 | 155 | 185 | 175 | 230 | 202 | 289 | 345 |
| Net profit | 140 | 117 | 130 | 132 | 182 | 164 | 211 | 254 |
| EPS (₹) | 46.47 | 36.93 | 42.97 | 43.40 | 60.88 | 54.60 | 71.38 | 83.32 |
| Segment | Revenue, ₹ crore | Share % |
|---|---|---|
| Life Science Chemicals | 1,805 | 27.8 |
| Performance and Other Chemicals | 3,464 | 53.3 |
| Others | 62 | 1.0 |
| Ohters | 19 | 0.3 |
| Performance and other chemicals | 1,145 | 17.6 |
| Total, before eliminations | 6,494 | 100.0 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 7 Sept 2026 · Atul Ltd appoints Vinayak Deshpande as Independent Director | management changes | medium | — | — |
| 8 Aug 2026 · Newspaper ad for postal ballot notice | compliance | minimal | — | — |
| 6 Aug 2026 · Postal ballot for appointing Vinayak Deshpande as Independent Director | board shareholder meetings | low | — | — |
| 5 Aug 2026 · AGM 2026 proceedings, Chairman speech and presentation uploaded | investor communications | medium | — | — |
| 31 Jul 2026 · Atul Ltd 49th AGM: All 5 resolutions passed, dividend declared | board shareholder meetings | medium | — | — |
| 31 Jul 2026 · Atul Ltd 49th AGM: FY26 results approved, dividend declared, MD reappointed | board shareholder meetings | low | — | — |
| 25 Jul 2026 · Newspaper publication of Q1 FY27 financial results | compliance | minimal | — | — |
| 24 Jul 2026 · Atul Q1 profit doubles YoY, appoints new Independent Director | management changes | medium | — | — |
| 24 Jul 2026 · Atul Ltd approves Rs 167 cr capex for new herbicide capacity | capex operations | high | — | — |
| 24 Jul 2026 · Atul Ltd Q1 FY27 results: revenue up 22%, PAT more than doubles YoY | results | high | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| PIDILITE INDUSTRIES LTD |
| 1,59,479 |
| 60.2 |
| 14.43 |
| 42.3 |
| 22.4 |
| 28.0 |
| 14.9 |
| 28.6 |
| SRF LTD | 73,583 | 34.0 | 5.24 | 22.7 | 13.1 | 13.1 | 13.4 | 25.2 |
| GUJARAT FLUOROCHEM LTD | 52,514 | 85.7 | 6.64 | 41.5 | 7.3 | 8.7 | 13.5 | 27.7 |
| NAVIN FLUORINE INT. LTD | 43,836 | 55.4 | 11.03 | 39.5 | 16.7 | 16.4 | 23.0 | 37.5 |
| AETHER INDUSTRIES LIMITED | 22,229 | 94.3 | 9.05 | 60.4 | 8.9 | 11.4 | — | 33.8 |
| DEEPAK NITRITE LTD | 21,769 | 27.8 | 3.71 | 22.4 | 9.4 | 10.2 | 12.6 | 21.5 |
| ATUL LTD ◆ | 18,401 | 23.1 | 2.92 | 14.9 | 10.9 | 13.3 | 10.9 | 23.1 |
| AARTI INDUSTRIES LTD | 17,846 | 33.6 | 3.00 | 18.8 | 7.0 | 4.4 | 13.0 | 16.2 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 23.1 | 23.4 | 51 of 103 | 51% |
| P/B | 2.9 | 2.9 | 53 of 99 | 47% |
| ROCE | 13.3 | 10.3 | 41 of 108 | 63% |
| ROE | 10.9 | 8.1 | 43 of 101 | 58% |
| Debt / Equity | 0.0 | 0.2 | 30 of 101 | 71% |
| EBITDA margin | 23.1 | 15.5 | 29 of 99 | 71% |
| Revenue growth | 25.0 | 24.4 | 45 of 94 | 53% |
| Profit growth | 91.8 | 55.1 | 32 of 92 | 66% |
| Market cap | 18401 | 732 | 7 of 107 | 94% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
